Prevention of DVT in ACL

Comparison of the efficacy of enoxaparin and aspirin in the prevention of deep venous thrombosis in patients undergoing orthostatic surgery for the reconstruction of anterior cruciate ligament

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20190325043107N7

Enrollment

120

Registered

2019-07-27

Start date

2019-07-01

Completion date

Unknown

Last updated

2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Deep vein thrombosis. Phlebitis and thrombophlebitis of other and unspecified deep vessels of lower extremities

Interventions

Intervention 1: Intervention group: Treatment with enoxaparin with a dose of 40 mg will be given daily and subcutaneously for 10 days. Intervention 2: Control group: Treatment with aspirin 325 mg twic

Eligibility

Sex/Gender

All

Age

19 Years to 55 Years

Inclusion criteria

Inclusion criteria: Candidate for surgical reconstruction of anterior cruciate ligament Age from 19 to 55 years

Exclusion criteria

Exclusion criteria: Weight greater than 100 kg

Design outcomes

Primary

Measure	Time frame
Deep vein thrombosis. Timepoint: Daily. Method of measurement: Sonography.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Mousavi Vaezi

Tabriz University of Medical Sciences

Drvaez@yahoo.com+98 41 3334 7054

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026